🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2750
-0.0143 (-4.94%)
At close: Nov 19, 2026, 4:00 PM EST
0.2870
+0.0120 (4.36%)
After-hours: Nov 19, 2026, 7:30 PM EST

Mereo BioPharma Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
446654232388174
Market Cap Growth
-84.41%-87.77%67.64%269.38%-49.64%-28.05%
Enterprise Value
18184682821750
Last Close Price
0.290.423.502.310.751.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----10.09
PS Ratio
57.26132.62-32.34-3.52
PB Ratio
1.951.628.896.401.701.46
P/TBV Ratio
1.941.648.996.541.702.02

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
25.3636.02-28.17-1.02

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.010.110.120.300.19
Net Debt / Equity Ratio
-1.08-1.00-1.04-1.02-1.03-0.88
Net Debt / EBITDA Ratio
0.891.081.401.941.013.72
Net Debt / FCF Ratio
1.161.321.932.441.0813.43
Asset Turnover
0.020.01-0.14-0.39
Quick Ratio
4.819.995.286.452.897.66
Current Ratio
5.2210.475.406.723.097.92
Return on Equity (ROE)
-76.63%-82.21%-77.58%-57.81%-53.63%34.85%
Return on Assets (ROA)
-44.51%-39.10%-39.99%-23.57%-28.67%-13.82%
Return on Invested Capital (ROIC)
------57.30%
Return on Capital Employed (ROCE)
-123.00%-91.90%-73.10%-47.60%-99.40%-18.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-52.00%-63.15%-7.98%-9.11%-48.22%9.91%
FCF Yield
-48.22%-46.74%-6.06%-6.54%-55.78%-4.50%
Buyback Yield / Dilution
-1.49%-7.77%-12.16%-9.33%-8.63%-63.82%
SEC Filings: 10-K · 10-Q